MRTNZ

MRTNZ Investment Office · S&P 500 · The 360 Vantage

MDT · NYSE

Medtronic plc. Ordinary Shares

Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus

Reference price$86.88As of Jul 28, 2026
Market capitalization$111B
52-week range$73.31–$106.33
S&P 500 portfolio weight0.17%
Data qualitycomplete

Street view

Analyst targets

Published sell-side aggregation—not an MRTNZ forecast.

Low$80.00-7.9% vs. reference
Average$95.53+10.0% vs. reference
High$118.00+35.8% vs. reference
13 Buy6 Hold0 Sell

Forward calendar

Current earnings expectations

Consensus may change until the company reports.

Expected reportSep 1, 2026Jul 2026
Consensus EPS$1.388 estimates
Expected range$1.36–$1.39Low to high EPS
Apr 2027$5.94Street EPS consensus
Apr 2028$6.38Street EPS consensus
Apr 2029$7.03Street EPS consensus

Reported results

Annual financial snapshot

Fiscal period ended Apr 24, 2026.

MetricCurrentPrior
Revenue+8.4% YoY$36.36B$33.54B
Operating income$6.47B$5.96B
Net income$4.8B$4.66B
Operating cash flow$7.33B$7.04B
Capital expenditures($1.9B)($1.86B)

Current context

Related news

Company-linked articles surfaced by Nasdaq.

Zacks

Abbott Rides Key Diabetes, Oncology and Heart Care Innovation Trends

NASDAQ.com

Pre-Market Most Active for Jul 28, 2026 : DFNS, MUU, TQQQ, FIRY, LVWR, SQQQ, TSLL, NOK, SKDD, MDT, GLW, TE

Zacks

Buy Texas Instruments as a Momentum Play After Solid Q2 2026 Earnings

Evidence

Sources & method

Nasdaq quote →Nasdaq summary →Earnings forecast →Annual financials →Official S&P 500-tracking holdings →

Facts, estimates, and scenarios are kept separate. Analyst targets and EPS expectations are third-party estimates, not MRTNZ forecasts. Index weight uses the official IVV portfolio as the denominator. Illustrative research, not investment advice.